JOHN M LEONARD
CIK 1563584 · President and CEO · last filed 2026-04-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$44.57M
Companies
6
Total Filings
66
Lifetime Open-Market Net
-$60.48M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IQV | Director | 16,946 | $181.46 | $3.08M | -$3.09M | 10 | 2026-04-27 |
| NTLA | President and CEO | 1,228,154 | $12.11 | $14.87M | -$54.68M | 38 | 2026-03-03 |
| CHIMERIX INC (CMRX) Delisted | Director | 4,000 | $8.54 | $34.2K | $138.2K | 6 | 2017-06-29 |
| Q | Director | 4,702 | $150.65 | $708.4K | $0 | 4 | 2017-05-25 |
| Vitae Pharmaceuticals, Inc (VTAE) Delisted | Director | — | — | — | $0 | 3 | 2016-10-25 |
| ABBV | SVP, Chief Scientific Officer | 113,793 | $227.73 | $25.91M | -$2.84M | 5 | 2013-03-19 |
Recent Filings · Page 2 of 7
66 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-01-05 | NTLA | Sell (S) | −19,223 | -$566.3K | EDGAR |
| 2024-01-03 | NTLA | Exer (M) | +7,848 | $0 | EDGAR |
| 2023-05-12 | IQV | Grant (A) | +1,063 | $0 | EDGAR |
| 2023-03-03 | NTLA | Grant (A) | +91,036 | $0 | EDGAR |
| 2023-01-06 | NTLA | Sell (S) | −6,673 | -$248.3K | EDGAR |
| 2023-01-04 | NTLA | Exer (M) | +7,848 | $0 | EDGAR |
| 2022-05-13 | IQV | Grant (A) | +995 | $0 | EDGAR |
| 2022-03-04 | NTLA | Mixed | +46,345 | -$279.9K | EDGAR |
| 2021-09-01 | NTLA | Mixed | — | -$17.45M | EDGAR |
| 2021-08-25 | NTLA | Mixed | — | -$3.76M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.